http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1458325-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
filingDate 1975-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1458325-A
titleOfInvention Nitroimidazolyl-s-triazolo-4,3-b-pyridazines
abstract 1458325 3-[5-Nitro-1-methyl-2-imidazolyl]-striazolo[4,3,-6]-pyridazines BOEHRINGER MANNHEIM GmbH 11 April 1975 [17 April 1974] 15030/75 Heading C2C Novel compounds (I) and their acid addition salts in which Z is methyl, amino or C 1-3 alkylamino are prepared by reacting a compound II with (i) a compound NH = C(Z)-NH 2 when X is halogen or a sulphonyl radical, (ii) a compound A-C(Y)(B)Z in which Y is C 1-6 alkoxy or alkylthio and A and B are alkoxy when X is amino, followed by reaction with ammonia or (iii) a nitrile Z-CN when X is amino, and if desired converting the compound obtained into a salt. Compounds I have anti-microbial activity and form with a carrier or diluent a pharmaceutical composition which may be administered orally or parenterally.
priorityDate 1974-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222

Total number of triples: 16.